The prevalence of anemia in patients with chronic kidney disease. - Wikidata - awgldk - TriplyDB

The prevalence of anemia in patients with chronic kidney disease.

The prevalence of anemia in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q45070902

about

Androgens for the anaemia of chronic kidney disease in adults Androgens for the anaemia of chronic kidney disease in adults Management of anemia in patients with diabetic kidney disease: A consensus statement Cardiovascular risk factors following renal transplant Pre-operative anaemia The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012)Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status Clinical management of nondialysis patients with chronic kidney disease: a retrospective observational study. Data from the SONDA study (Survey Of Non-Dialysis outpAtients)Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: a pooled analysis of individual patient-level data from clinical trials.Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study.Anemia and thrombocytopenia in acute and chronic renal failure.The role of anemia management in improving outcomes for African-Americans with chronic kidney disease Transfusion burden among patients with chronic kidney disease and anemia.A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia.Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.Modeling red blood cell survival data.Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.Factors affecting employment at initiation of dialysis.Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility.Anemia in patients on chronic hemodialysis in Cameroon: prevalence, characteristics and management in low resources setting.C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis.Cognitive function and dialysis adequacy: no clear relationship Predictors of anemia in a multi-ethnic chronic kidney disease population: a case-control study.Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study.Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients.Renal denervation in moderate to severe CKD.Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients.C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.Diabetes: changing the fate of diabetics in the dialysis unit.Renal anaemia: recent developments, innovative approaches and future directions for improved management.Chronic kidney disease and its complications.

P2860

Q24193138-AB90C25D-3816-4A65-AA53-5D46C435D7AD Q24242990-5C3B891E-8BF5-4097-9E13-71CF11122BD1 Q26752692-145DDCCF-3FBD-4CF2-9A12-8C3B652AB86D Q26771406-1B0C6304-14E6-41F5-AA5D-F03CD798F101 Q26998362-48D651C0-9517-46EE-8625-05E8857773FE Q28553538-1B67A2DA-5423-4483-8B5E-B89B50CD9A14 Q28646953-C88E8698-576E-4287-9E05-F61056AA1DDE Q28648176-5E4AA968-C283-4EBA-BE98-8D94F877D996 Q30611154-2D535EDF-A2FE-4B5A-8159-3D54D2BAAA56 Q31108646-C4258855-BF7A-4031-98EA-B79559014C5A Q33412594-91979D45-8E95-49B9-9A13-59E591EFF33A Q33413205-F30A45AD-8F68-47B9-BCFE-81F2AAECEF6B Q33646679-6199D298-3D2A-4D1B-B432-DFC11A162FFD Q33770069-4E24DC39-E340-4E08-ABF5-6EEEBE4D5A93 Q33770093-2393EF48-7D4D-4224-B98B-B8DF40D897AB Q33801065-1BC8423A-FE1F-4A11-ADD3-2F678C461185 Q33985849-E4A687EA-9C29-4599-8D3B-BC87DC672A05 Q34047965-DE6884F1-72B8-4D63-AD31-6D9FC292C13B Q34138258-7D783613-6682-4490-85F8-03A14D8FD7E5 Q34538362-54F7EBFA-55A1-4FBC-9F27-1BCCD10C81AA Q34751907-5745DD1D-EFBF-43A2-BC73-648CD232DEFD Q34857566-4F06DC1B-1F23-4F5C-8E31-FB98AC9BB63B Q35020305-5DE37F8C-E27C-454C-878D-478AB16C758B Q35088131-841767BA-FB34-4B4C-8715-D0E493825792 Q35162053-1701DC94-B477-4B78-96F7-8FB40E544407 Q35207391-E5748866-B00B-48B7-BD8C-74172B9409BF Q35573212-C0554127-2620-4E2B-9DC3-9793C7B0319E Q35633286-C2D960B9-4AF5-4455-8D4C-682FD9C4610D Q35811858-B1EDD11D-C56D-487A-8B46-DF3536826A0D Q35886023-242304A9-2C60-48CD-806E-D522669347C8 Q35936604-A1C5DEA3-CC8D-4031-B331-61A4789FABF9 Q36009530-D93BF343-3456-4C31-ADD0-EDA33BE0BABC Q36050927-C68287BF-32C2-4EF2-8C75-62D38E457D9F Q36285948-2E603326-9F09-49EE-9D8B-296150B4A65F Q36409830-90289027-0510-4FE4-A438-8CCCE76F8FE6 Q36457268-A64200DF-227E-487F-A523-03058E7D743E Q36666810-CC396961-3D64-4EEF-9EEB-D0C46F493803 Q36684720-C02E4E72-2BB5-433C-B6C8-E1EE7AFADA27 Q36697772-27ECAEF2-B2BC-4474-92F6-97A99F14B439 Q36776175-5D9C6D6B-F8BA-4A0D-AAFF-1A50AB36A7EE

P2860

The prevalence of anemia in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q45070902

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

The prevalence of anemia in patients with chronic kidney disease.

@en

The prevalence of anemia in patients with chronic kidney disease.

@nl

type

label

The prevalence of anemia in patients with chronic kidney disease.

@en

The prevalence of anemia in patients with chronic kidney disease.

@nl

prefLabel

The prevalence of anemia in patients with chronic kidney disease.

@en

The prevalence of anemia in patients with chronic kidney disease.

@nl

P1433

Q45070902-1F5A7979-2692-40B5-BFE7-0E9DDEC78E53

P1476

Q45070902-8B3D929D-7F7A-4B56-9B98-2FC11D8EC19B

P2093

Q45070902-0B50A3CD-6409-4724-A82C-EE275B422894

Q45070902-14401B2B-0752-4F24-B980-F9850EC04C1C

Q45070902-32FACFCB-4D43-41F2-874E-5FCCABFA2CE6

Q45070902-74BF77B1-2FAC-49E5-B562-2C25F5741DC9

Q45070902-7E92C8D4-16F6-4FDB-8DA0-5E0AEFDBA5D7

Q45070902-801882D6-DE8D-4950-A3D2-534A44677C77

Q45070902-999EDB80-25C8-4034-8676-11E10BB6ECD2

Q45070902-F73C05C9-60CC-47FF-BC52-300034180AF1

Q45070902-F843D86E-D49E-4434-884B-1899059206FA

P304

Q45070902-EE69CC74-BC28-4835-9196-B50AE29C2EA6

P31

Q45070902-5BD597EE-128E-4CC2-98A4-AED04FD96BF7

P356

Q45070902-CBDF954F-62DE-4057-9DA3-8B059FFE1C05

P407

Q45070902-1DE9AC5A-EC69-425C-B39F-EAB6B3A39CF0

P433

Q45070902-68CEB0F1-5482-42E2-910A-FC1EB2C56CB3

P478

Q45070902-4112C26E-B989-4622-9133-5F8B9D881C2C

P577

Q45070902-8DF120F0-BF62-4FEE-8690-65AC20C864A6

P698

Q45070902-956F0897-8B72-4D96-9220-6DF105BC0A99

P921

Q45070902-165AA0EC-A893-4284-9BF3-4B37DEAF760F

P356

P1433

Current Medical Research and Opinion

P1476

The prevalence of anemia in patients with chronic kidney disease.

@en

P2093

Brian Wasserman

http://www.w3.org/2001/XMLSchema#string

Daniel L Lorber

http://www.w3.org/2001/XMLSchema#string

K Linda Tang

http://www.w3.org/2001/XMLSchema#string

Marc Leiserowitz

http://www.w3.org/2001/XMLSchema#string

Sally Hood

http://www.w3.org/2001/XMLSchema#string

Stephen L Aronoff

http://www.w3.org/2001/XMLSchema#string

Thomas F Tse

http://www.w3.org/2001/XMLSchema#string

W Kline Bolton

http://www.w3.org/2001/XMLSchema#string

William McClellan

http://www.w3.org/2001/XMLSchema#string

P304

1501-1510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1185/030079904X2763

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15383200

http://www.w3.org/2001/XMLSchema#string

P921